Today, Tuesday, the US “Pfizer” submitted a request to the US Food and Drug Administration for emergency permission to provide a fourth dose of the “Covid-19” vaccine to Americans 65 years of age and older.
Pfizer provided data on the fourth dose to the regulators, a joint venture with the German company “Biontech”, according to the American newspaper “Washington Post”.
And 3 people familiar with the matter confirmed to the newspaper that the initiative comes to enhance the diminished immunity, several months after receiving the first dose.
The data presented to the US Food and Drug Administration on Tuesday is expected to be “real world data” collected in Israel, one of the few countries that has allowed a second batch of seniors to be introduced.
And it was hinted at providing a fourth dose for several months, and Pfizer CEO Albert Borla revealed, during a television appearance last week, that his company would soon submit its offer for a fourth dose.